Urticaria and Red cell distribution width increased

Summary:

Red cell distribution width increased is found among people with Urticaria, especially for people who are male, 50-59 old.

The study analyzes which people have Red cell distribution width increased with Urticaria. It is created by eHealthMe based on reports of 16 people who have Urticaria from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,624 drugs and 2,951 conditions by eHealthMe. Check the latest studies of Urticaria.

What is Red cell distribution width increased?

Red cell distribution width increased is found to be associated with 607 drugs and 653 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.



On Jul, 06, 2026

16 people who have Urticaria and Red Cell Distribution Width Increased are studied.

Would you have Red cell distribution width increased when you have Urticaria?

Gender of people who have Urticaria and experienced Red Cell Distribution Width Increased *:

  • female: 43.75 %
  • male: 56.25 %

Age of people who have Urticaria and experienced Red Cell Distribution Width Increased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 13.33 %
  • 30-39: 6.67 %
  • 40-49: 0.0 %
  • 50-59: 80.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 25.00%
  2. Thyroid Diseases: 1 person, 6.25%
  3. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 1 person, 6.25%
  4. Pain: 1 person, 6.25%
  5. Nausea (feeling of having an urge to vomit): 1 person, 6.25%
  6. Joint Swelling: 1 person, 6.25%
  7. Fever: 1 person, 6.25%
  8. Cough: 1 person, 6.25%
  9. Asthma: 1 person, 6.25%
  10. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 6.25%

Common drugs taken by these people *:

  1. Benadryl: 13 people, 81.25%
  2. Prednisone: 9 people, 56.25%
  3. Risedronate Sodium: 8 people, 50.00%
  4. Colchicine: 8 people, 50.00%
  5. Actemra: 8 people, 50.00%
  6. Methotrexate: 7 people, 43.75%
  7. Gravol: 6 people, 37.50%
  8. Sulfasalazine: 4 people, 25.00%
  9. Paracetamol: 4 people, 25.00%
  10. Biotin: 4 people, 25.00%

Common symptoms for these people *:

  1. Lymphocyte Count Decreased: 15 people, 93.75%
  2. Headache (pain in head): 12 people, 75.00%
  3. Joint Pain: 11 people, 68.75%
  4. Diarrhea: 11 people, 68.75%
  5. Eosinophil Count Increased: 10 people, 62.50%
  6. Drowsiness: 9 people, 56.25%
  7. Stress And Anxiety: 9 people, 56.25%
  8. Asthma: 9 people, 56.25%
  9. Abdominal Pain Upper: 9 people, 56.25%
  10. Thrombocytopenia (decrease of platelets in blood): 9 people, 56.25%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Red cell distribution width increased?

- Check whether Red cell distribution width increased is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Red cell distribution width increased:

All the conditions that are associated with Red cell distribution width increased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Red cell distribution width increased and Urticaria, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: